|
Jul 29
|
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
|
|
Jul 25
|
Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Jun 22
|
When Will Ardelyx, Inc. (NASDAQ:ARDX) Become Profitable?
|
|
May 22
|
Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
|
|
May 16
|
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
|
|
May 7
|
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
|
|
May 4
|
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript
|
|
May 4
|
Ardelyx First Quarter 2024 Earnings: Beats Expectations
|
|
May 3
|
Q1 2024 Ardelyx Inc Earnings Call
|
|
May 2
|
Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
May 1
|
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
|
|
Apr 30
|
Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
|
|
Apr 25
|
Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Apr 23
|
Ardelyx's (NASDAQ:ARDX) investors will be pleased with their favorable 91% return over the last five years
|
|
Apr 18
|
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
|
|
Apr 2
|
The Millionaire’s Shortcut: 3 Stocks to Transform Your Portfolio This Month
|
|
Mar 25
|
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
|
|
Mar 21
|
Institutional investors may overlook Ardelyx, Inc.'s (NASDAQ:ARDX) recent US$195m market cap drop as long-term gains remain positive
|
|
Mar 16
|
The Clock is Ticking: 3 Stocks Set to Explode in the Next Quarter
|